Please assess the completion status of the following clinical trial:

Trial Title: Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult female lupus nephritis patients, currently having a flare of lupus nephritis and considering change or initiation of an immunosuppressive medication (current flare) or had had flare of lupus nephritis in the past and at risk for a future lupus nephritis flare (future flare)~Exclusion Criteria:~* male; lupus but no lupus nephritis; change in lupus immunosuppressive treatment already made for current flare; end stage renal disease on dialysis; renal transplant or candidate for a renal transplant

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Computerized patient decision-aid (Type: EXPERIMENTAL): A computerized decision-aid showing benefits and harms of medications in words patients prefer
- Usual care (lupus pamphlet) (Type: ACTIVE_COMPARATOR): A handout/pamphlet from a non-profit organization on lupus and lupus medications (American College of Rheumatology \[ACR\])

Based on this trial design, predict the completion outcome and termination type (if applicable).